Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions ...
Recently, the novel oral BET inhibitor NHWD-870 HCI, independently developed by Zhejiang Wenda Pharmaceutical Technology Co., Ltd., officially received ...
Chance Pharmaceuticals ('Chance' or 'Chance Pharma'), a clinical-stage biotechnology company dedicated to the research and ...
Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.
US drug pricing policy and Congressional Budget Office (CBO) model of the Build Back Better Act examining pharmaceutical R&D ...
Vietnam Investment Review on MSN
Chance Pharma drug application accepted by NMPA for respiratory treatment CXG87
HANGZHOU, China, May 8, 2026 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative ...
The discussions also reviewed recent initiatives aimed at enhancing quality of life and supporting the sustainability of the ...
Former Edgewise and Merck leader brings more than 15 years’ experience to guide Immutrin’s clinical strategy as the Company ...
This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science.
Germany’s approach to drug pricing is a textbook example of how developed nations shift the cost of medical progress onto ...
(Yicai) May 8 -- China will grant manufacturers of eligible innovative pediatric drugs a market exclusivity period of up to ...
The Establishment’s presence yielded tangible outcomes, including strategic partnerships, industrial empowerment programmes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results